POP-OUT | CLOSE
 
 
(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
 
LFX is found in 3 entries
LFX
  •   Chemical Component Summary   Hide
    Name (3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid
    Identifiers
    Synonyms Levofloxacin
    Formula C18 H20 F N3 O4
    Molecular Weight 361.37 g/mol
    Type non-polymer
    Isomeric SMILES
    InChI
    InChI key GSDSWSVVBLHKDQ-JTQLQIEISA-N
     
  •   Drug Info: DrugBank Hide
    DrugBank ID DB01137   (Stereoisomeric match)
    Name Levofloxacin
    Groups approved
    Description A synthetic fluoroquinolone (fluoroquinolones) antibacterial agent that inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication. [PubChem]
    Synonyms L-Ofloxacin
    Brand names
    • Cravit
    • Cravit Ophthalmic
    • Elequine
    • Floxel
    • Iquix
    • Leroxacin
    • Lesacin
    • Levaquin
    • Levokacin
    • Levox
    • Levoxacin
    • Mosardal
    • Nofaxin
    • Quixin
    • Reskuin
    • Tavanic
    • Volequin
    [more]
    Affected organism Enteric bacteria and other eubacteria
    Indication For the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: <i>Corynebacterium</i> species, <i>Staphylococus aureus</i>, <i>Staphylococcus epidermidis</i>, <i>Streptococcus pneumoniae</i>, <i>Streptococcus</i> (Groups C/F/G), Viridans group streptococci, <i>Acinetobacter lwoffii</i>, <i>Haemophilus influenzae</i>, <i>Serratia marcescens</i>.
    Pharmacology Levofloxacin, a fluoroquinolone antiinfective, is the optically active L-isomer of ofloxacin. Levofloxacin is used to treat bacterial conjunctivitis, sinusitis, chronic bronchitis, community-acquired pneumonia and pneumonia caused by penicillin-resistant strains of <i>Streptococcus pneumoniae</i>, skin and skin structure infections, complicated urinary tract infections and acute pyelonephritis.
    Mechanism of action Levofloxacin inhibits bacterial type II topoisomerases, topoisomerase IV and DNA gyrase. Levofloxacin, like other fluoroquinolones, inhibits the A subunits of DNA gyrase, two subunits encoded by the gyrA gene. This results in strand breakage on a bacterial chromosome, supercoiling, and resealing; DNA replication and transcription is inhibited.
    Route of administration
    • Intravenous
    • Oral
    Categories
    • Anti-Bacterial Agents
    • Quinolones
    • Nucleic Acid Synthesis Inhibitors
    • Anti-Infective Agents, Urinary
    ATC-Code
    • J01MA12
    • S01AE05
    AHFS-Code 08:12.18
    CAS number 100986-85-4
    Targets
    Name Sequence search Pharmacological action Actions
    DNA topoisomerase 4 subunit A   Search  yes inhibitor
    DNA gyrase subunit A   Search  yes inhibitor
    DNA topoisomerase 2-alpha   Search  yes inhibitor
     
Ligand Image